XDH and gout: Xanthine oxidoreductase (XOR), the key enzyme catalyzing the oxidation of hypoxanthine and xanthine to urate, is the drug target for the most widely used urate-lowering therapy (ULT) medications for gout and HU, allopurinol and to a lesser extent febuxostat [10].